Article info

Original research
Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition

Authors

  1. Correspondence to Dr Nilasha Ghosh; ghoshn{at}hss.edu
View Full Text

Citation

Ghosh N, Postow M, Zhu C, et al
Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition

Publication history

  • Accepted January 1, 2022
  • First published January 28, 2022.
Online issue publication 
January 28, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.